drugset / Trial / NCT00211991

Evaluation of Consistency of StaphVAX Manufacturing Lots

NCT00211991 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This study answers a U.S. Food and Drug Administration requirement for evaluation in people of the consistency of manufacturing of a vaccine. Subjects are randomized to one of three lots of vaccine. The antibodies in the blood measure the immunogenicity of each lot of vaccine, and typical vaccine safety information is also collected.

Timeline

Start
2005-04
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject StaphVAX Vaccine — —